Inscription Capital’s Eastman Chemical EMN Stock Holding History

Inscription Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,605	Closed	-$418K	–	648
2025 Q2	$418K	Buy	+5,605	New	+$440K	0.06%	262

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Inscription Capital's EMN Position: Q3 2025 in Review

Inscription Capital sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 5,605 shares — an estimated $418K sold.

Inscription Capital first reported a position in EMN in Q2 2025 and held it in 1 quarter. The position peaked at $418K in Q2 2025. 664 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

Inscription Capital reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
Inscription Capital sold 5,605 Eastman Chemical shares in Q3 2025, an estimated $418K.
Inscription Capital first reported a position in Eastman Chemical in Q2 2025 and held it in 1 quarter.
Inscription Capital's Eastman Chemical position peaked at $418K in Q2 2025.
664 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Inscription Capital's 13F filing for Q3 2025, filed 29 Oct 2025.